Financials
Financial year 2025
APOTEEK LEFEVER-FEYAERTS from Overijse, company number BE0460761183, closed financial year 2025 with a result of € 6,801 after tax. For that financial year APOTEEK LEFEVER-FEYAERTS recorded a gross margin of € -2,681 and equity of € 283,322. Compared with financial year 2024, the result moved from € -3,909 to € 6,801. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 283,322
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 6,801
▲ still € 3,909 loss in 2024
Profit after tax over the fiscal year.
€ 27,851
▼ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 221,322.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 316
▼ 78% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 136,265 | € 80,834 | € -11,272 | € -2,681 | ▲ € 8,590 |
| Profit after taxes | € 42,878 | € -14,139 | € -3,909 | € 6,801 | ▲ € 10,710 |
| Equity | € 294,570 | € 280,431 | € 276,522 | € 283,322 | ▲ 2% |
| Total debts | € 76,782 | € 55,804 | € 1,423 | € 316 | ▼ 78% |
| Cash | € 177,857 | € 208,347 | € 31,039 | € 27,851 | ▼ 10% |
| Retained profit | € 232,570 | € 218,431 | € 214,522 | € 221,322 | ▲ 3% |
| Balance sheet total | € 371,352 | € 336,235 | € 277,945 | € 283,638 | ▲ 2% |
Key figures of APOTEEK LEFEVER-FEYAERTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTEEK LEFEVER-FEYAERTS?
What happened at APOTEEK LEFEVER-FEYAERTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 6,801. Source: NBB ↗
- FARMACENTER BV became a director. NBB
- BENEPHARMA BV became a director. NBB
- VALAPHARMA BV became a director. NBB
- APOTHEEK BARBIER-DENEYER BV became a director. NBB
- New establishment in Overijse. KBO
- Start of the company according to the CBE. KBO
In short
From € 42,878 profit in 2022 to € 6,801 profit in 2025.
Paid € 15,808 in corporate taxes since 2022.
Best year ever: 2022, with € 42,878 profit.
Management
The stake of VALAPHARMA, Farmacenter, APOTHEEK BARBIER - DENEYER, BENEPHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTEEK LEFEVER-FEYAERTSBehind APOTEEK LEFEVER-FEYAERTS are FARMACENTER BV, BENEPHARMA BV, VALAPHARMA BV and APOTHEEK BARBIER-DENEYER BV. The shares are held by VALAPHARMA (30%), Farmacenter (26.8%), APOTHEEK BARBIER - DENEYER (26.6%) and BENEPHARMA (16.6%).
Directors
According to the 2025 annual accounts
Director · represented by Maisin Marie-Anne
since 2024
Director · represented by Vermeulen Benedicte
since 2024
Director · represented by Levie Valérie
Also active at: APOTHEEK TENNSTEDT-LEVIE, G.L.PHARMA
since 2024
Director · represented by Barbier Luc
since 2024
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Brusselsesteenweg 225
3090 Overijse
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0460.761.183
- VAT number
- BE 0460.761.183
- Registered office
- Brusselsesteenweg 225, 3090 Overijse
- Names & denominations
- APOTEEK LEFEVER-FEYAERTS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 May 1997
- Peppol
- Active · Active since 13 Jan 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers